When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial

Open Access

Scott Evans

Scott Evans is with the Center for Biostatistics in AIDS Research, Department of Biostatistics, at the Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America. E-mail: evans@sdac.harvard.edu
⨯

Reader Comments (1)

Medical journals
Is the Subject Area "Medical journals" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Coronary artery bypass grafting
Is the Subject Area "Coronary artery bypass grafting" applicable to this article?

Thanks for your feedback.
Decision making
Is the Subject Area "Decision making" applicable to this article?

Thanks for your feedback.
Lipids
Is the Subject Area "Lipids" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Statistical data
Is the Subject Area "Statistical data" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.